A “Contract win with FORD Otosan”-titled announcement today from company which describes itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA). What of the shares currently towards 20p in response, around 10% down?
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) is today “delighted to announce… a three-year contract with LIBERTY Galati, the largest integrated steel producer in Romania”. Noted to be its largest single contract to-date, what of a current 9.2% higher share price response to 47.5p here?
Directa Plus (DCTA) has announced that it has demonstrated on a pilot scale in Romania a “new decontamination solution” for produced water, which comes out of wells during crude oil production, and “is now working with an existing major customer in Romania to transport this new solution for treating produced water inside one of their oil production areas, starting to operate as soon as possible, before rolling out the solution to customers globally”. What of though currently a muted share price response from 68.5p?
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) has issued a “New product launch” announcement including a headline “Partnership to introduce GRAPHITO, a ground-breaking eco-denim textile, marks a milestone in the sustainable fashion industry”. So what’s the detail and what of a current 69.5p share price?
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) has announced 2022 calendar year results emphasising “Strong performance delivers revenue ahead of market expectations and solid growth across the group”. So what of a share price slightly up to 72p in response?
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) has announced that it “now expects revenues for FY22 to be not less than €10.8m, as a result of a strong performance in December, which represents a c.25% increase on the prior year” and that there is current “robust growth across all verticals supported by a strengthening pipeline of potential opportunities”. So what of a share price presently up to 86p?
Previously writing on company describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA), in October with the shares up to 89.5p I concluded that its recent announcements and above £59 million market cap meant that I retained caution, still avoid/sell. The shares last closed at 83.8p but are currently falling well below 80p on the back of a “trading update”.
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) emphasises a “first commercial contract in Latin America” and the shares have currently responded up to 89.5p.
Directa Plus (DCTA) has announced “a significant validation of our product… asphalt for the A4 Torino-Milano motorway section, managed by the ASTM Group will be made with G+ graphene”. So what of a current share price of 87.5p, up more than 14% on this news?
Writing on company which describes itself as “a leading producer and supplier of graphene-based products for use in consumer and industrial markets” Directa Plus (DCTA) at the start of this month with the shares just below 90p I concluded, ahead of the half-year financial detail, still avoid / sell. So what of the now-announced results and the shares more than 12% lower at 76.5p?
Writing on company which describes itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) earlier this week, I noted US patents development and “generating considerable interest”, but what about the financials?. So what of now a “pleased to provide… trading update ahead of the announcement of its half year results for the six months to 30 June 2022 on 29 September”?
Describing itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets”, Directa Plus (DCTA) has announced it “has received a Notice of Allowance from the United States Patent and Trademark Office for the grant of a patent covering the Company's G+ embedded polyurethane membrane”, with the offering “generating considerable interest in the US market”. So what of a current 90p share price?
Producer and supplier of graphene nanoplatelets-based products Directa Plus (DCTA) has announced 2021 results emphasising “revenue and profitability which have exceeded consensus market expectations” and “a number of exciting opportunities in our targeted markets”. So what of a current 121.5p share price?...
Shares in company which describes itself as “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) are currently further higher today to 123p on the back of a “US EPA Authorises Grafysorber for Use in US”-titled announcement. What does this latest here mean?...
Having commenced November at a 136p share price, two subsequent announcements have helped shares in Directa Plus (DCTA) up to a current 160p. So what’s this latest news from this ‘graphene nanoplatelets-based products’ company?...
Previously writing on graphene nanoplatelets-based products company Directa Plus (DCTA), in June I concluded with the shares at 121.5p, having expressed cash burn concern, I continued to avoid. Today an “Additional Italian Government Covid Recovery Loan” announcement.
Self-styled “a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets” Directa Plus (DCTA) “is pleased to report that this strong revenue growth is continuing in the last two months of the current first half”. What does it mean financially?...
